Check with the doctor, nurse or pharmacist before using these tablets, if the patient: is having problems with bowel movements because of a blockage of the gut (intestines); has heart problems, is being treated for cancer with a medicine that is known to damage the heart or has problems with levels of salts, such as potassium, sodium or calcium, in the body (electrolyte abnormalities); is taking other '5-HT3 receptor antagonist' medicines. These include dolasetron, ondansetron used like Granisetron Actavis in the treatment and prevention of nausea and vomiting.
Cases of life-threatening serotonin syndrome have been reported with 5-HT3 receptor antagonist antiemetics, particularly when given in combination with other serotonergic and/or neuroleptic drugs. Treatment should be discontinued if such events occur and supportive symptomatic treatment should be initiated. If concomitant treatment of Granisetron Actavis with a drug affecting the serotonergic neurotransmitter system is clinically warranted, careful observations of the patient is advised, particularly during treatment initiation and dose increases.
Important information about some of the ingredients of Granisetron Actavis: Granisetron Actavis contains lactose (a type of sugar). If the patient has been told by the doctor to have an intolerance to some sugars, contact the doctor before taking this medicinal product.
Effects on the Ability to Drive or Operate Machinery: Granisetron Actavis has no or negligible effect on the ability to drive or use any tools or machines
Children: Children should not take these tablets.